Step by Stepa HemeOncBuddy patient portal

Adagrasib

Illustration: Adagrasib

Say it: ad-uh-GRA-sib · Brand names: Krazati

Adagrasib is a targeted pill that blocks a growth signal in cancers with a KRAS G12C gene change.

What it is

Some cancers have a change in a gene called KRAS, known as G12C. This change keeps a growth switch turned on. Adagrasib locks the switch in the off position.

Often used for

How you get it

It is a pill you take by mouth twice a day, with or without food. People usually take it for as long as it works. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Adagrasib?
Adagrasib is a targeted pill that blocks a growth signal in cancers with a KRAS G12C gene change. Brand names: Krazati.
What is Adagrasib used for?
non-small cell lung cancer with a KRAS G12C change; colorectal cancer with a KRAS G12C change, together with the antibody cetuximab.
How is Adagrasib given?
It is a pill you take by mouth twice a day, with or without food. People usually take it for as long as it works. Your schedule may be different.
What are the common side effects of Adagrasib?
Nausea and vomiting. Diarrhea. Feeling tired. Less appetite. Swelling in the legs or feet. Muscle or bone pain. Changes in liver or kidney blood tests.
When should I call my care team while taking Adagrasib?
Vomiting or diarrhea that will not stop, or you cannot keep fluids down; Yellow skin or eyes, dark urine, or pain on the right side of your belly; A fast, slow, or pounding heartbeat, or feeling like you might faint; New or worse cough, shortness of breath, or chest pain; Peeing much less than normal.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.